50 mg Bicalutamide Tablets IP

Get a Price/Quote

Product Details:

Click to view more
Share Your Product:

Ask A Question Send Inquiry

X

Product Description

50 mg Bicalutamide Tablets IP are the ones is indicated for use in combination therapy with a luteinizing hormone-releasing hormone (LHRH) analog for the treatment of Stage D 2 metastatic carcinoma of the prostate. 50 mg Bicalutamide Tablets IP are minutely tested on diverse parameters before the final dispatching from our unit.

RAVI WORLDWIDE MEDICINES PRIVATE LIMITED